Marble

The company exists because of a death. Bateman's father-in-law was dying of cancer in 2013, seeing physicians across four hospitals with two home care agencies and a GP involved, and it fell to Bateman's mother-in-law to carry the paper between them. His co-founder Derrick Chow was going through something similar with his own family. They pitched the idea at the University of Toronto's Entrepreneurship Hatchery in January 2015 and raised $700,000 from two local angels straight off demo day. The first product was direct-to-consumer — get anyone their own complete medical record — and it did not grow. Bateman told the TechTO audience in April 2018 that the pivot to B2B was the moment everything fell into place: personal injury lawyers, medical researchers and life insurance underwriters all needed health data, and the legal ground was that the patient, not the hospital, owns the information. The company raised $17 million across seed and Series A rounds led by Crosslink Capital and Golden Ventures, renamed itself Marble in 2022 and repositioned around the API rather than the retrieval service — the pitch Bateman uses is that Marble wants to be for health data what Plaid became for bank data. Medchart survives as the brand for records retrieval, and by 2026 was positioned around Canadian clinical research, saying it connects EMR, pharmacy, lab and claims data across more than 2,000 hospital and clinic sites.